Alert Indications, Safety, and Warnings

EVOLUT PRO+ SYSTEM Transcatheter Aortic Valve Replacement (TAVR)

The next generation EvolutTM PRO+ transcatheter aortic valve system provides industry-leading hemodynamics — allowing your patients to return to activity faster.1,2,3 

DOWNLOAD BROCHURE
Beauty shot of the Evolut Pro+ system heart valve
Alert Indications, Safety, and Warnings

Overview

Meet the Evolut PRO+ SYSTEM

With a design built on the proven Evolut platform, the Evolut PRO+ system features:

icon for lowest delivery profile

Low delivery profile
for access down to 5.0 mm vessels with the 23-29 mm valves. 

icon for advanced sealing

Advanced sealing
for all valve sizes with the addition of the external tissue wrap to the 34 mm valve. 

PRODUCT DETAILS

EXCEPTIONAL DESIGN

Today, the Evolut PRO+ valve design means no tradeoffs.

It provides the lowest delivery profile and added surface area contact between the valve and the native aortic annulus to further advance valve sealing performance.

In addition, our exceptional valve design is taking patient outcomes above and beyond — contributing to our industry-leading hemodynamics.

SEE HEMODYNAMIC DATA

Evolut Pro+ valve with a pericardial wrap

TREAT MORE PATIENTS

The Evolut PRO+ TAVI system is indicated to treat annulus ranges up to 30 mm diameter and has the ability to treat the broadest annulus range* for self-expanding TAVI available in the market.

Evolut valves in all 4 sizes including 23, 26, 29 and 34 mm, depicting the treatable annulus range from 17 to 30 mm

CONTROL DURING DEPLOYMENT

The Evolut PRO+ delivery system:

  • Assists in accurate positioning of the valve
  • Features a 1:1 response for immediate feedback between the deployment knob and the movement of the capsule
  • Provides you the option to recapture and reposition4 for more accurate placement

Image of the EnVeo PRO delivery system featuring accurate positioning

RESOURCES

MANUALS AND TECHNICAL GUIDES

Access instructions for use and other technical manuals in the Medtronic Manual Library. Search by the product name (e.g., Evolut) or model number.

EVOLUT PRO+ PLATFORM RESOURCES

pdf Barcode and Ordering Information (.pdf)

368KB

Barcode and Ordering Information
pdf Product Specifications (.pdf)

330KB

Product Specifications
pdf Evolut PRO+ Product Brochure (.pdf)

6.1MB

Evolut PRO+ Product Brochure

  STAY INFORMED

Receive email updates about Medtronic TAVI.

FOLLOW US:
@MDT_StructHeart

REQUEST MORE INFORMATION

CONTACT US

EDUCATION & RESOURCES

Find additional feature information, educational resources, and tools.

VISIT MEDTRONIC ACADEMY
*

Broadest annulus range based on CT derived diameters.

References

1

Bleiziffer S, Eichinger WB, Hettich I, et al. Impact of patient-prosthesis mismatch on exercise capacity in patients after bioprosthesis aortic valve replacement. Heart. May 2008;94(5):637-641.

2

van Slooten YJ, van Melle JP, Freling HG, et al. Aortic valve prosthesis-patient mismatch and exercise capacity in adult patients with congenital heart disease. Heart. January 2016;102(2):107-113.

3

Pibarot P, Dumesnil JG, Jobin J, Cartier P, Honos G, Durand LG. Hemodynamic and physical performance during maximal exercise in patients with an aortic bioprosthetic valve: comparison of stentless versus stented bioprostheses. J Am Coll Cardiol. November 1, 1999;34(5):1609-1617.

4

Up to 80% deployment. The valve can be partially or fully recaptured up to three times prior to the point of no recapture. Third attempt must be a complete recapture and retrieval from patient.